TipRanks
Advertisement
Advertisement
Evolent Health upgraded to Buy from Neutral at Citi
PremiumThe FlyEvolent Health upgraded to Buy from Neutral at Citi
1M ago
Evolent Health price target lowered to $6 from $7 at Canaccord
Premium
The Fly
Evolent Health price target lowered to $6 from $7 at Canaccord
1M ago
Evolent Health Earnings Call Balances Growth and Risk
Premium
Company Announcements
Evolent Health Earnings Call Balances Growth and Risk
1M ago
Evolent Health: Near-Term Upside Seen as Limited; Hold Rating Reaffirmed with Unchanged $7 Price Target Amid Valuation and Policy Risks
PremiumRatingsEvolent Health: Near-Term Upside Seen as Limited; Hold Rating Reaffirmed with Unchanged $7 Price Target Amid Valuation and Policy Risks
3M ago
Evolent Health Shareholders Approve Proposals at 2026 Meeting
Premium
Company Announcements
Evolent Health Shareholders Approve Proposals at 2026 Meeting
3M ago
Evolent Health price target raised to $5.50 from $4 at Citi
Premium
The Fly
Evolent Health price target raised to $5.50 from $4 at Citi
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100